Matthew Manry, MD
Retina Specialist · Longmont, CONPI 1366735243
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $28,061 of the $43,207 with a category attached, or 64.9%. Apellis Pharmaceuticals, Inc. accounts for 72.8% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2023 at $28,733 and has fallen 97.2% since, to $810 in 2025. Among retina specialist clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $219.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$31K
- F. Hoffmann-la Roche AG$4K
- AbbVie$3K
- Alimera Sciences, Inc.$1K
- Genentech USA, Inc.$728
- Eyepoint US, Inc.$633
- plus $2K from 22 others
Across 55 payments — averaging $3335.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$130K
- Regeneron$53K
What the payments were for
- Consulting fees$6,98916%
- Speaking & faculty fees$28,06165%
- Travel & lodging$2,8367%
- Food & beverage$5,30712%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 51 | $31,459 |
| F. Hoffmann-la Roche AG | 2 | $3,794 |
| AbbVie(2 entities) | 11 | $3,276 |
| Alimera Sciences, Inc. | 16 | $1,415 |
| Genentech USA, Inc. | 37 | $728 |
| Eyepoint US, Inc. | 5 | $633 |
| Regeneron Healthcare Solutions, Inc. | 18 | $473 |
| Genentech, Inc. | 14 | $300 |
| Novartis | 7 | $202 |
| Topcon Healthcare, Inc. | 4 | $191 |
| Astellas Pharma US Inc | 4 | $103 |
| Bausch & Lomb Americas Inc. | 4 | $91 |
| Heidelberg Engineering, Inc. | 2 | $88 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Biogen | 3 | $56 |
| Mallinckrodt Hospital Products Inc. | 3 | $51 |
| Spark Therapeutics, Inc. | 2 | $43 |
| Rxsight Inc | 2 | $35 |
| ANI Pharmaceuticals, Inc. | 2 | $35 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $21 |
| Alcon | 1 | $21 |
| Tarsus Pharmaceuticals, Inc. | 1 | $21 |
| Regeneron | 1 | $18 |
| Coherus Oncology, Inc. | 1 | $18 |
| Optos, Inc. | 1 | $16 |
| Glaukos Corporation | 1 | $15 |
| Notal Vision, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$43,207 in reported general payments places this provider in the 90th percentile of 51 retina specialist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 116 | $5,625 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 56 | $906 |
| Ketorolac Tromethamine | 34 | $732 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 55 | $474 |
| Atropine Sulfate | 12 | $473 |
| Latanoprost | 17 | $311 |
| Timolol Maleate | 12 | $110 |
| Brimonidine Tartrate | 15 | $59 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Longmont
- Justin KanoffLongmont$4K
- Carl NobleLongmont$3K
- William BenedictLongmont$599
- Murtaza AdamParker$548K
- Alan KimuraDenver$546K
- Brian JoondephDenver$92K
- Talisa ForestAurora$84K
- Sara HaugDurango$59K
- Ashleigh LevisonLafayette$33K
- Mimi LiuEnglewood$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.